BGN Eye Hospital
BGN Eye Hospital
République de Corée, Pusan
En Corée du Sud, le traitement de la dystrophie maculaire coûte généralement entre $4,500 et $8,500. Le tarif final dépend de la thérapie choisie, comme les injections intravitréennes, le laser ou la chirurgie. En France, ces interventions coûtent environ $8,000. Les patients économisent environ 44% par rapport aux prix français. Les forfaits incluent souvent les diagnostics préopératoires, des examens complets et un accompagnement pour les patients internationaux.
Avis d'expert Bookimed : Les hôpitaux numériques comme le Seoul National University Bundang Hospital (SNUBH) garantissent une sécurité optimale grâce à leurs systèmes informatisés. Pour les soins ophtalmologiques, le BGN Eye Hospital à Busan réalise plus de 346 000 interventions de correction visuelle. L'Asan Medical Center, classé parmi les meilleurs hôpitaux du monde par Newsweek, offre des soins de premier plan. Ces établissements allient des normes certifiées JCI à des tarifs bien inférieurs à ceux observés en Occident.
Pourquoi choisir la République de Corée pour le traitement de la dystrophie maculaire ?
Accédez à des solutions avancées pour le traitement de la dystrophie maculaire dans des cliniques de confiance .
Bookimed ne facture pas de frais supplémentaires pour les prix des Traitement de la dystrophie maculaire. Les tarifs sont issus des listes de prix officielles des cliniques. Vous payez directement à la clinique lors de votre arrivée pour votre Traitement de la dystrophie maculaire.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans Traitement de la dystrophie maculaire et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de Traitement de la dystrophie maculaire.
South Korea offers high-density ophthalmology care. Leading institutions include BGN Eye Hospital, Asan Medical Centre, and Gangnam Severance Hospital. These centres lead the region in retinal diagnostics and vision correction. They hold certifications from Joint Commission International and Newsweek as smart hospitals.
Bookimed Expert Insight: While major Seoul hospitals handle thousands of general cases, specialised centres like BGN Eye Hospital in Busan often provide better value for international patients. They include free translators and 1-day hotel stays for surgery. Larger university hospitals rarely bundle these into their treatment fees.
Patient Consensus: Confirm if the diagnosis is genetic macular dystrophy or age-related degeneration before travelling to Republic of Korea. Specialists there are excellent for managing symptoms and providing routine injections. You can receive these while on holiday.
South Korean hospitals lead in ophthalmology by offering gene therapies like Luxturna for inherited retinal degeneration. Major centres including Samsung Medical Center and Seoul National University Bundang Hospital provide advanced diagnostics and intravitreal injections. These help manage symptoms and preserve vision for patients with specific genetic mutations.
Bookimed Expert Insight: South Korea is a hub for approved gene therapies. However, experimental treatments like the KAIST antibody therapy remain in the pre-clinical phase. Patients should prioritise clinics with Global Healthcare Accreditation (GHA), such as SNUBH. These clinics follow specific safety protocols for international cases.
Patient Consensus: Clinics in South Korea offer precise genetic screening to confirm if newer therapies match a patient's mutation. The support from personal coordinators and free translators makes navigating complex eye treatments much easier.
Macular dystrophy treatment in South Korea involves digital pre-screening, retina specialist consultations, and diagnostics like 3D eye mapping. Patients access anti-VEGF injections or laser eye surgery at JCI-accredited facilities. Specialised clinics like BGN Eye Hospital and Asan Medical Center streamline care for international arrivals through dedicated coordinators and translators.
Bookimed Expert Insight: South Korea's high-volume centres include BGN Eye Hospital, which has performed 346,000+ vision correction surgeries. These centres offer significant technical reliability. Patients should confirm if their package includes the free one-day hotel stay. This helps recovery before long-haul flights back to Australia.
Patient Consensus: Coordination is vital for international patients as clinics use a mix of English and Korean. Patients should confirm the diagnosis with an Australian genetic specialist before travel. This helps the clinic choice suit the specific condition.
South Korean ophthalmologists primarily use Optical Coherence Tomography (OCT) to diagnose macular dystrophy. This high-resolution imaging captures cross-sectional retinal layers to identify thinning or fluid. Other critical tools include Fundus Autofluorescence (FAF), widefield photography, and fluorescein angiography to monitor disease progression and retinal health.
Bookimed Expert Insight: While imaging is standard, tertiary centres like Seoul National University Bundang Hospital (SNUBH) integrate digital "smart" systems to track minute structural changes over time. South Korea's high volume of digital eye screenings means clinics often possess more comprehensive historical data than average facilities. For a precise dystrophy diagnosis, patients should confirm if the facility offers electroretinography (ERG). Simple OCT scans may not distinguish genetic dystrophy from age-related degeneration.
Patient Consensus: Patients find that OCT imaging in South Korea is quick and non-invasive. They often receive high-resolution retinal maps and detailed progression reports during their initial diagnostic appointments.